Zymaxid ophthalmic solution approved for bacterial conjunctivitis - ONA
Links shared publicly online about this topic.
- 1,154total visits
Zymaxid ophthalmic solution approved for bacterial conjunctivitis - ONA
View full resource at oncologynurseadvisor.com
Tags: Eye Infection, Conjunctivitis, FDA
Most Recently Shared on May 20, 2010 at 3:23 pm By:
Zymaxid ophthalmic solution approved for bacterial conjunctivitis http://goo.gl/fb/sDmLT
Hi-Tech Pharmacal Receives Final Approval For Levofloxacin Ophthalmic Solution - QualityPoint Technologies
qualitypointtech.net — “Hi-Tech Pharmacal Co., Inc. (NASDAQ:HITK), a specialty pharmaceuticals company, announced that the US Food and Drug Administration, (FDA) granted final approval for the Company's Abbreviated New Drug Application, (ANDA) for levofloxacin ophthalmic solution, 0.5% the generic for Vistakon's Quixin® ophthalmic solution, which had sales of $2 million for the 12 months ended December 2010 according to IMS sales data. The product is indicated for bacterial conjunctivitis. The Company is preparing ” View full resource at qualitypointtech.net
Most Recently Shared on February 13, 2011 at 11:35 am By:
Hi-Tech Pharmacal Receives Final Approval For Levofloxacin Ophthalmic Solution: Hi-Tech Pharmacal Co., Inc. (NASDA... http://bit.ly/edWqEF
Zymaxid ophthalmic solution approved for bacterial conjunctivitis - MPR
empr.com — “The FDA has approved Allergan's Zymaxid (gatifloxacin ophthalmic solution) 0.5%, a topical fluoroquinolone, for the treatment of bacterial conjunctivitis caused by susceptible organisms.” View full resource at empr.com
Most Recently Shared on May 20, 2010 at 3:23 pm By:
Zymaxid ophthalmic solution approved for bacterial conjunctivitis: The FDA has approved Allergan's Zymaxid (gatifl... http://bit.ly/cjMmKJ
Zymaxid ophthalmic solution approved for bacterial conjunctivitis - MPR
empr.com — “The FDA has approved Allergan's Zymaxid (gatifloxacin ophthalmic solution) 0.5%, a topical fluoroquinolone, for the treatment of bacterial conjunctivitis caused by susceptible organisms.” View full resource at empr.com
Most Recently Shared on May 20, 2010 at 2:46 pm By:
MPR News: Zymaxid ophthalmic solution approved for bacterial conjunctivitis: The FDA has approved Allergan's Zymax... http://bit.ly/clFJJU
FDA approves ZYMAXID ophthalmic solution for treatment of bacterial conjunctivitis
news-medical.net — “Allergan, Inc. today announced that the United States Food and Drug Administration has approved ZYMAXID (gatifloxacin ophthalmic solution) 0.5%, a topical fluoroquinolone anti-infective indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms; Haemophilus influenzae, Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus mitis group, Streptococcus oralis, Streptococcus pneumonia.” View full resource at news-medical.net
Most Recently Shared on May 20, 2010 at 8:27 am By:
Obesity News: FDA approves ZYMAXID ophthalmic solution for treatment of bacterial conjunctivitis: Allergan, Inc.... http://twurl.nl/fcuc3y
Allergan Receives FDA Approval for Zymaxid Ophthalmic Solution
drugs.com — “Zymaxid (gatifloxacin ophthalmic solution) is used to treat bacterial conjunctivitis. Includes Zymaxid side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on May 19, 2010 at 11:38 pm By:
Allergan Receives FDA Approval for Zymaxid Ophthalmic Solution - http://bit.ly/dndI0j
Advertisement
